Global Passive Immunizing Drugs against Rabies Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Passive Immunizing Drugs against Rabies market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
Passive immunization against rabies refers to the administration of pre-formed antibodies,to provide immediate but temporary protection against the rabies virus.This approach delivers antibodies directly to neutralize the virus and prevent it from spreading,offering short-term immunity while the recipient's own immune system is stimulated by the rabies vaccine to develop a long-lasting immune response,which is especially critical in the early stages following potential exposure to rabies.
This report is a detailed and comprehensive analysis for global Passive Immunizing Drugs against Rabies market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Global Passive Immunizing Drugs against Rabies market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global Passive Immunizing Drugs against Rabies market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global Passive Immunizing Drugs against Rabies market shares of main players, shipments in revenue ($ Million), sales quantity (K Dose), and ASP (US$/Dose), 2021-2026
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Chapter 2, to profile the top manufacturers of Passive Immunizing Drugs against Rabies, with price, sales quantity, revenue, and global market share of Passive Immunizing Drugs against Rabies from 2021 to 2026.
Chapter 3, the Passive Immunizing Drugs against Rabies competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Passive Immunizing Drugs against Rabies breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Passive Immunizing Drugs against Rabies market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Passive Immunizing Drugs against Rabies.
Chapter 14 and 15, to describe Passive Immunizing Drugs against Rabies sales channel, distributors, customers, research findings and conclusion.
Passive immunization against rabies refers to the administration of pre-formed antibodies,to provide immediate but temporary protection against the rabies virus.This approach delivers antibodies directly to neutralize the virus and prevent it from spreading,offering short-term immunity while the recipient's own immune system is stimulated by the rabies vaccine to develop a long-lasting immune response,which is especially critical in the early stages following potential exposure to rabies.
This report is a detailed and comprehensive analysis for global Passive Immunizing Drugs against Rabies market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Passive Immunizing Drugs against Rabies market size and forecasts, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032Global Passive Immunizing Drugs against Rabies market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global Passive Immunizing Drugs against Rabies market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global Passive Immunizing Drugs against Rabies market shares of main players, shipments in revenue ($ Million), sales quantity (K Dose), and ASP (US$/Dose), 2021-2026
The Primary Objectives in This Report Are:
- To determine the size of the total market opportunity of global and key countries
- To assess the growth potential for Passive Immunizing Drugs against Rabies
- To forecast future growth in each product and end-use market
- To assess competitive factors affecting the marketplace
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Passive Immunizing Drugs against Rabies market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.Market segment by Type
- Rabies Immunoglobulin
- Anti-rabies Serum
- Rabies Virus Monoclonal Antibody
Market segment by Application
- Category II Exposure
- Category III Exposure
Major players covered
- Kedrion Biopharma
- Grifols
- Sanofi Pasteur
- Kamada
- Zydus Lifesciences
- Serum Institute of India
- Sichuan Yuanda Shuyang Pharmaceutical
- Sinopharm Group
- Haffkine Bio-Pharmaceutical
- Bharat Biotech
- Sharon Bio-Medicine
- Wuhan Institute of Biological Products
- North China Pharmaceutical
- Xingmeng Biopharmaceuticals (Suzhou)
- Hualan Biological Engineering
- Shanxi Kangbao Biological Product
Market segment by region, regional analysis covers
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Passive Immunizing Drugs against Rabies product scope, market overview, market estimation caveats and base year.Chapter 2, to profile the top manufacturers of Passive Immunizing Drugs against Rabies, with price, sales quantity, revenue, and global market share of Passive Immunizing Drugs against Rabies from 2021 to 2026.
Chapter 3, the Passive Immunizing Drugs against Rabies competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Passive Immunizing Drugs against Rabies breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Passive Immunizing Drugs against Rabies market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Passive Immunizing Drugs against Rabies.
Chapter 14 and 15, to describe Passive Immunizing Drugs against Rabies sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Passive Immunizing Drugs against Rabies Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 Rabies Immunoglobulin
1.3.3 Anti-rabies Serum
1.3.4 Rabies Virus Monoclonal Antibody
1.4 Market Analysis by Application
1.4.1 Overview: Global Passive Immunizing Drugs against Rabies Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.4.2 Category II Exposure
1.4.3 Category III Exposure
1.5 Global Passive Immunizing Drugs against Rabies Market Size & Forecast
1.5.1 Global Passive Immunizing Drugs against Rabies Consumption Value (2021 & 2025 & 2032)
1.5.2 Global Passive Immunizing Drugs against Rabies Sales Quantity (2021-2032)
1.5.3 Global Passive Immunizing Drugs against Rabies Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Kedrion Biopharma
2.1.1 Kedrion Biopharma Details
2.1.2 Kedrion Biopharma Major Business
2.1.3 Kedrion Biopharma Passive Immunizing Drugs against Rabies Product and Services
2.1.4 Kedrion Biopharma Passive Immunizing Drugs against Rabies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Kedrion Biopharma Recent Developments/Updates
2.2 Grifols
2.2.1 Grifols Details
2.2.2 Grifols Major Business
2.2.3 Grifols Passive Immunizing Drugs against Rabies Product and Services
2.2.4 Grifols Passive Immunizing Drugs against Rabies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Grifols Recent Developments/Updates
2.3 Sanofi Pasteur
2.3.1 Sanofi Pasteur Details
2.3.2 Sanofi Pasteur Major Business
2.3.3 Sanofi Pasteur Passive Immunizing Drugs against Rabies Product and Services
2.3.4 Sanofi Pasteur Passive Immunizing Drugs against Rabies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Sanofi Pasteur Recent Developments/Updates
2.4 Kamada
2.4.1 Kamada Details
2.4.2 Kamada Major Business
2.4.3 Kamada Passive Immunizing Drugs against Rabies Product and Services
2.4.4 Kamada Passive Immunizing Drugs against Rabies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Kamada Recent Developments/Updates
2.5 Zydus Lifesciences
2.5.1 Zydus Lifesciences Details
2.5.2 Zydus Lifesciences Major Business
2.5.3 Zydus Lifesciences Passive Immunizing Drugs against Rabies Product and Services
2.5.4 Zydus Lifesciences Passive Immunizing Drugs against Rabies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Zydus Lifesciences Recent Developments/Updates
2.6 Serum Institute of India
2.6.1 Serum Institute of India Details
2.6.2 Serum Institute of India Major Business
2.6.3 Serum Institute of India Passive Immunizing Drugs against Rabies Product and Services
2.6.4 Serum Institute of India Passive Immunizing Drugs against Rabies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Serum Institute of India Recent Developments/Updates
2.7 Sichuan Yuanda Shuyang Pharmaceutical
2.7.1 Sichuan Yuanda Shuyang Pharmaceutical Details
2.7.2 Sichuan Yuanda Shuyang Pharmaceutical Major Business
2.7.3 Sichuan Yuanda Shuyang Pharmaceutical Passive Immunizing Drugs against Rabies Product and Services
2.7.4 Sichuan Yuanda Shuyang Pharmaceutical Passive Immunizing Drugs against Rabies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Sichuan Yuanda Shuyang Pharmaceutical Recent Developments/Updates
2.8 Sinopharm Group
2.8.1 Sinopharm Group Details
2.8.2 Sinopharm Group Major Business
2.8.3 Sinopharm Group Passive Immunizing Drugs against Rabies Product and Services
2.8.4 Sinopharm Group Passive Immunizing Drugs against Rabies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Sinopharm Group Recent Developments/Updates
2.9 Haffkine Bio-Pharmaceutical
2.9.1 Haffkine Bio-Pharmaceutical Details
2.9.2 Haffkine Bio-Pharmaceutical Major Business
2.9.3 Haffkine Bio-Pharmaceutical Passive Immunizing Drugs against Rabies Product and Services
2.9.4 Haffkine Bio-Pharmaceutical Passive Immunizing Drugs against Rabies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Haffkine Bio-Pharmaceutical Recent Developments/Updates
2.10 Bharat Biotech
2.10.1 Bharat Biotech Details
2.10.2 Bharat Biotech Major Business
2.10.3 Bharat Biotech Passive Immunizing Drugs against Rabies Product and Services
2.10.4 Bharat Biotech Passive Immunizing Drugs against Rabies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Bharat Biotech Recent Developments/Updates
2.11 Sharon Bio-Medicine
2.11.1 Sharon Bio-Medicine Details
2.11.2 Sharon Bio-Medicine Major Business
2.11.3 Sharon Bio-Medicine Passive Immunizing Drugs against Rabies Product and Services
2.11.4 Sharon Bio-Medicine Passive Immunizing Drugs against Rabies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Sharon Bio-Medicine Recent Developments/Updates
2.12 Wuhan Institute of Biological Products
2.12.1 Wuhan Institute of Biological Products Details
2.12.2 Wuhan Institute of Biological Products Major Business
2.12.3 Wuhan Institute of Biological Products Passive Immunizing Drugs against Rabies Product and Services
2.12.4 Wuhan Institute of Biological Products Passive Immunizing Drugs against Rabies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Wuhan Institute of Biological Products Recent Developments/Updates
2.13 North China Pharmaceutical
2.13.1 North China Pharmaceutical Details
2.13.2 North China Pharmaceutical Major Business
2.13.3 North China Pharmaceutical Passive Immunizing Drugs against Rabies Product and Services
2.13.4 North China Pharmaceutical Passive Immunizing Drugs against Rabies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 North China Pharmaceutical Recent Developments/Updates
2.14 Xingmeng Biopharmaceuticals (Suzhou)
2.14.1 Xingmeng Biopharmaceuticals (Suzhou) Details
2.14.2 Xingmeng Biopharmaceuticals (Suzhou) Major Business
2.14.3 Xingmeng Biopharmaceuticals (Suzhou) Passive Immunizing Drugs against Rabies Product and Services
2.14.4 Xingmeng Biopharmaceuticals (Suzhou) Passive Immunizing Drugs against Rabies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Xingmeng Biopharmaceuticals (Suzhou) Recent Developments/Updates
2.15 Hualan Biological Engineering
2.15.1 Hualan Biological Engineering Details
2.15.2 Hualan Biological Engineering Major Business
2.15.3 Hualan Biological Engineering Passive Immunizing Drugs against Rabies Product and Services
2.15.4 Hualan Biological Engineering Passive Immunizing Drugs against Rabies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 Hualan Biological Engineering Recent Developments/Updates
2.16 Shanxi Kangbao Biological Product
2.16.1 Shanxi Kangbao Biological Product Details
2.16.2 Shanxi Kangbao Biological Product Major Business
2.16.3 Shanxi Kangbao Biological Product Passive Immunizing Drugs against Rabies Product and Services
2.16.4 Shanxi Kangbao Biological Product Passive Immunizing Drugs against Rabies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 Shanxi Kangbao Biological Product Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: PASSIVE IMMUNIZING DRUGS AGAINST RABIES BY MANUFACTURER
3.1 Global Passive Immunizing Drugs against Rabies Sales Quantity by Manufacturer (2021-2026)
3.2 Global Passive Immunizing Drugs against Rabies Revenue by Manufacturer (2021-2026)
3.3 Global Passive Immunizing Drugs against Rabies Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Passive Immunizing Drugs against Rabies by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Passive Immunizing Drugs against Rabies Manufacturer Market Share in 2025
3.4.3 Top 6 Passive Immunizing Drugs against Rabies Manufacturer Market Share in 2025
3.5 Passive Immunizing Drugs against Rabies Market: Overall Company Footprint Analysis
3.5.1 Passive Immunizing Drugs against Rabies Market: Region Footprint
3.5.2 Passive Immunizing Drugs against Rabies Market: Company Product Type Footprint
3.5.3 Passive Immunizing Drugs against Rabies Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Passive Immunizing Drugs against Rabies Market Size by Region
4.1.1 Global Passive Immunizing Drugs against Rabies Sales Quantity by Region (2021-2032)
4.1.2 Global Passive Immunizing Drugs against Rabies Consumption Value by Region (2021-2032)
4.1.3 Global Passive Immunizing Drugs against Rabies Average Price by Region (2021-2032)
4.2 North America Passive Immunizing Drugs against Rabies Consumption Value (2021-2032)
4.3 Europe Passive Immunizing Drugs against Rabies Consumption Value (2021-2032)
4.4 Asia-Pacific Passive Immunizing Drugs against Rabies Consumption Value (2021-2032)
4.5 South America Passive Immunizing Drugs against Rabies Consumption Value (2021-2032)
4.6 Middle East & Africa Passive Immunizing Drugs against Rabies Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global Passive Immunizing Drugs against Rabies Sales Quantity by Type (2021-2032)
5.2 Global Passive Immunizing Drugs against Rabies Consumption Value by Type (2021-2032)
5.3 Global Passive Immunizing Drugs against Rabies Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Passive Immunizing Drugs against Rabies Sales Quantity by Application (2021-2032)
6.2 Global Passive Immunizing Drugs against Rabies Consumption Value by Application (2021-2032)
6.3 Global Passive Immunizing Drugs against Rabies Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America Passive Immunizing Drugs against Rabies Sales Quantity by Type (2021-2032)
7.2 North America Passive Immunizing Drugs against Rabies Sales Quantity by Application (2021-2032)
7.3 North America Passive Immunizing Drugs against Rabies Market Size by Country
7.3.1 North America Passive Immunizing Drugs against Rabies Sales Quantity by Country (2021-2032)
7.3.2 North America Passive Immunizing Drugs against Rabies Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe Passive Immunizing Drugs against Rabies Sales Quantity by Type (2021-2032)
8.2 Europe Passive Immunizing Drugs against Rabies Sales Quantity by Application (2021-2032)
8.3 Europe Passive Immunizing Drugs against Rabies Market Size by Country
8.3.1 Europe Passive Immunizing Drugs against Rabies Sales Quantity by Country (2021-2032)
8.3.2 Europe Passive Immunizing Drugs against Rabies Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific Passive Immunizing Drugs against Rabies Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Passive Immunizing Drugs against Rabies Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Passive Immunizing Drugs against Rabies Market Size by Region
9.3.1 Asia-Pacific Passive Immunizing Drugs against Rabies Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific Passive Immunizing Drugs against Rabies Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America Passive Immunizing Drugs against Rabies Sales Quantity by Type (2021-2032)
10.2 South America Passive Immunizing Drugs against Rabies Sales Quantity by Application (2021-2032)
10.3 South America Passive Immunizing Drugs against Rabies Market Size by Country
10.3.1 South America Passive Immunizing Drugs against Rabies Sales Quantity by Country (2021-2032)
10.3.2 South America Passive Immunizing Drugs against Rabies Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Passive Immunizing Drugs against Rabies Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Passive Immunizing Drugs against Rabies Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Passive Immunizing Drugs against Rabies Market Size by Country
11.3.1 Middle East & Africa Passive Immunizing Drugs against Rabies Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa Passive Immunizing Drugs against Rabies Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 Passive Immunizing Drugs against Rabies Market Drivers
12.2 Passive Immunizing Drugs against Rabies Market Restraints
12.3 Passive Immunizing Drugs against Rabies Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Passive Immunizing Drugs against Rabies and Key Manufacturers
13.2 Manufacturing Costs Percentage of Passive Immunizing Drugs against Rabies
13.3 Passive Immunizing Drugs against Rabies Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Passive Immunizing Drugs against Rabies Typical Distributors
14.3 Passive Immunizing Drugs against Rabies Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Passive Immunizing Drugs against Rabies Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 Rabies Immunoglobulin
1.3.3 Anti-rabies Serum
1.3.4 Rabies Virus Monoclonal Antibody
1.4 Market Analysis by Application
1.4.1 Overview: Global Passive Immunizing Drugs against Rabies Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.4.2 Category II Exposure
1.4.3 Category III Exposure
1.5 Global Passive Immunizing Drugs against Rabies Market Size & Forecast
1.5.1 Global Passive Immunizing Drugs against Rabies Consumption Value (2021 & 2025 & 2032)
1.5.2 Global Passive Immunizing Drugs against Rabies Sales Quantity (2021-2032)
1.5.3 Global Passive Immunizing Drugs against Rabies Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Kedrion Biopharma
2.1.1 Kedrion Biopharma Details
2.1.2 Kedrion Biopharma Major Business
2.1.3 Kedrion Biopharma Passive Immunizing Drugs against Rabies Product and Services
2.1.4 Kedrion Biopharma Passive Immunizing Drugs against Rabies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Kedrion Biopharma Recent Developments/Updates
2.2 Grifols
2.2.1 Grifols Details
2.2.2 Grifols Major Business
2.2.3 Grifols Passive Immunizing Drugs against Rabies Product and Services
2.2.4 Grifols Passive Immunizing Drugs against Rabies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Grifols Recent Developments/Updates
2.3 Sanofi Pasteur
2.3.1 Sanofi Pasteur Details
2.3.2 Sanofi Pasteur Major Business
2.3.3 Sanofi Pasteur Passive Immunizing Drugs against Rabies Product and Services
2.3.4 Sanofi Pasteur Passive Immunizing Drugs against Rabies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Sanofi Pasteur Recent Developments/Updates
2.4 Kamada
2.4.1 Kamada Details
2.4.2 Kamada Major Business
2.4.3 Kamada Passive Immunizing Drugs against Rabies Product and Services
2.4.4 Kamada Passive Immunizing Drugs against Rabies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Kamada Recent Developments/Updates
2.5 Zydus Lifesciences
2.5.1 Zydus Lifesciences Details
2.5.2 Zydus Lifesciences Major Business
2.5.3 Zydus Lifesciences Passive Immunizing Drugs against Rabies Product and Services
2.5.4 Zydus Lifesciences Passive Immunizing Drugs against Rabies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Zydus Lifesciences Recent Developments/Updates
2.6 Serum Institute of India
2.6.1 Serum Institute of India Details
2.6.2 Serum Institute of India Major Business
2.6.3 Serum Institute of India Passive Immunizing Drugs against Rabies Product and Services
2.6.4 Serum Institute of India Passive Immunizing Drugs against Rabies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Serum Institute of India Recent Developments/Updates
2.7 Sichuan Yuanda Shuyang Pharmaceutical
2.7.1 Sichuan Yuanda Shuyang Pharmaceutical Details
2.7.2 Sichuan Yuanda Shuyang Pharmaceutical Major Business
2.7.3 Sichuan Yuanda Shuyang Pharmaceutical Passive Immunizing Drugs against Rabies Product and Services
2.7.4 Sichuan Yuanda Shuyang Pharmaceutical Passive Immunizing Drugs against Rabies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Sichuan Yuanda Shuyang Pharmaceutical Recent Developments/Updates
2.8 Sinopharm Group
2.8.1 Sinopharm Group Details
2.8.2 Sinopharm Group Major Business
2.8.3 Sinopharm Group Passive Immunizing Drugs against Rabies Product and Services
2.8.4 Sinopharm Group Passive Immunizing Drugs against Rabies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Sinopharm Group Recent Developments/Updates
2.9 Haffkine Bio-Pharmaceutical
2.9.1 Haffkine Bio-Pharmaceutical Details
2.9.2 Haffkine Bio-Pharmaceutical Major Business
2.9.3 Haffkine Bio-Pharmaceutical Passive Immunizing Drugs against Rabies Product and Services
2.9.4 Haffkine Bio-Pharmaceutical Passive Immunizing Drugs against Rabies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Haffkine Bio-Pharmaceutical Recent Developments/Updates
2.10 Bharat Biotech
2.10.1 Bharat Biotech Details
2.10.2 Bharat Biotech Major Business
2.10.3 Bharat Biotech Passive Immunizing Drugs against Rabies Product and Services
2.10.4 Bharat Biotech Passive Immunizing Drugs against Rabies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Bharat Biotech Recent Developments/Updates
2.11 Sharon Bio-Medicine
2.11.1 Sharon Bio-Medicine Details
2.11.2 Sharon Bio-Medicine Major Business
2.11.3 Sharon Bio-Medicine Passive Immunizing Drugs against Rabies Product and Services
2.11.4 Sharon Bio-Medicine Passive Immunizing Drugs against Rabies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Sharon Bio-Medicine Recent Developments/Updates
2.12 Wuhan Institute of Biological Products
2.12.1 Wuhan Institute of Biological Products Details
2.12.2 Wuhan Institute of Biological Products Major Business
2.12.3 Wuhan Institute of Biological Products Passive Immunizing Drugs against Rabies Product and Services
2.12.4 Wuhan Institute of Biological Products Passive Immunizing Drugs against Rabies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Wuhan Institute of Biological Products Recent Developments/Updates
2.13 North China Pharmaceutical
2.13.1 North China Pharmaceutical Details
2.13.2 North China Pharmaceutical Major Business
2.13.3 North China Pharmaceutical Passive Immunizing Drugs against Rabies Product and Services
2.13.4 North China Pharmaceutical Passive Immunizing Drugs against Rabies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 North China Pharmaceutical Recent Developments/Updates
2.14 Xingmeng Biopharmaceuticals (Suzhou)
2.14.1 Xingmeng Biopharmaceuticals (Suzhou) Details
2.14.2 Xingmeng Biopharmaceuticals (Suzhou) Major Business
2.14.3 Xingmeng Biopharmaceuticals (Suzhou) Passive Immunizing Drugs against Rabies Product and Services
2.14.4 Xingmeng Biopharmaceuticals (Suzhou) Passive Immunizing Drugs against Rabies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Xingmeng Biopharmaceuticals (Suzhou) Recent Developments/Updates
2.15 Hualan Biological Engineering
2.15.1 Hualan Biological Engineering Details
2.15.2 Hualan Biological Engineering Major Business
2.15.3 Hualan Biological Engineering Passive Immunizing Drugs against Rabies Product and Services
2.15.4 Hualan Biological Engineering Passive Immunizing Drugs against Rabies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 Hualan Biological Engineering Recent Developments/Updates
2.16 Shanxi Kangbao Biological Product
2.16.1 Shanxi Kangbao Biological Product Details
2.16.2 Shanxi Kangbao Biological Product Major Business
2.16.3 Shanxi Kangbao Biological Product Passive Immunizing Drugs against Rabies Product and Services
2.16.4 Shanxi Kangbao Biological Product Passive Immunizing Drugs against Rabies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 Shanxi Kangbao Biological Product Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: PASSIVE IMMUNIZING DRUGS AGAINST RABIES BY MANUFACTURER
3.1 Global Passive Immunizing Drugs against Rabies Sales Quantity by Manufacturer (2021-2026)
3.2 Global Passive Immunizing Drugs against Rabies Revenue by Manufacturer (2021-2026)
3.3 Global Passive Immunizing Drugs against Rabies Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Passive Immunizing Drugs against Rabies by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Passive Immunizing Drugs against Rabies Manufacturer Market Share in 2025
3.4.3 Top 6 Passive Immunizing Drugs against Rabies Manufacturer Market Share in 2025
3.5 Passive Immunizing Drugs against Rabies Market: Overall Company Footprint Analysis
3.5.1 Passive Immunizing Drugs against Rabies Market: Region Footprint
3.5.2 Passive Immunizing Drugs against Rabies Market: Company Product Type Footprint
3.5.3 Passive Immunizing Drugs against Rabies Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Passive Immunizing Drugs against Rabies Market Size by Region
4.1.1 Global Passive Immunizing Drugs against Rabies Sales Quantity by Region (2021-2032)
4.1.2 Global Passive Immunizing Drugs against Rabies Consumption Value by Region (2021-2032)
4.1.3 Global Passive Immunizing Drugs against Rabies Average Price by Region (2021-2032)
4.2 North America Passive Immunizing Drugs against Rabies Consumption Value (2021-2032)
4.3 Europe Passive Immunizing Drugs against Rabies Consumption Value (2021-2032)
4.4 Asia-Pacific Passive Immunizing Drugs against Rabies Consumption Value (2021-2032)
4.5 South America Passive Immunizing Drugs against Rabies Consumption Value (2021-2032)
4.6 Middle East & Africa Passive Immunizing Drugs against Rabies Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global Passive Immunizing Drugs against Rabies Sales Quantity by Type (2021-2032)
5.2 Global Passive Immunizing Drugs against Rabies Consumption Value by Type (2021-2032)
5.3 Global Passive Immunizing Drugs against Rabies Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Passive Immunizing Drugs against Rabies Sales Quantity by Application (2021-2032)
6.2 Global Passive Immunizing Drugs against Rabies Consumption Value by Application (2021-2032)
6.3 Global Passive Immunizing Drugs against Rabies Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America Passive Immunizing Drugs against Rabies Sales Quantity by Type (2021-2032)
7.2 North America Passive Immunizing Drugs against Rabies Sales Quantity by Application (2021-2032)
7.3 North America Passive Immunizing Drugs against Rabies Market Size by Country
7.3.1 North America Passive Immunizing Drugs against Rabies Sales Quantity by Country (2021-2032)
7.3.2 North America Passive Immunizing Drugs against Rabies Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe Passive Immunizing Drugs against Rabies Sales Quantity by Type (2021-2032)
8.2 Europe Passive Immunizing Drugs against Rabies Sales Quantity by Application (2021-2032)
8.3 Europe Passive Immunizing Drugs against Rabies Market Size by Country
8.3.1 Europe Passive Immunizing Drugs against Rabies Sales Quantity by Country (2021-2032)
8.3.2 Europe Passive Immunizing Drugs against Rabies Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific Passive Immunizing Drugs against Rabies Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Passive Immunizing Drugs against Rabies Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Passive Immunizing Drugs against Rabies Market Size by Region
9.3.1 Asia-Pacific Passive Immunizing Drugs against Rabies Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific Passive Immunizing Drugs against Rabies Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America Passive Immunizing Drugs against Rabies Sales Quantity by Type (2021-2032)
10.2 South America Passive Immunizing Drugs against Rabies Sales Quantity by Application (2021-2032)
10.3 South America Passive Immunizing Drugs against Rabies Market Size by Country
10.3.1 South America Passive Immunizing Drugs against Rabies Sales Quantity by Country (2021-2032)
10.3.2 South America Passive Immunizing Drugs against Rabies Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Passive Immunizing Drugs against Rabies Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Passive Immunizing Drugs against Rabies Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Passive Immunizing Drugs against Rabies Market Size by Country
11.3.1 Middle East & Africa Passive Immunizing Drugs against Rabies Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa Passive Immunizing Drugs against Rabies Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 Passive Immunizing Drugs against Rabies Market Drivers
12.2 Passive Immunizing Drugs against Rabies Market Restraints
12.3 Passive Immunizing Drugs against Rabies Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Passive Immunizing Drugs against Rabies and Key Manufacturers
13.2 Manufacturing Costs Percentage of Passive Immunizing Drugs against Rabies
13.3 Passive Immunizing Drugs against Rabies Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Passive Immunizing Drugs against Rabies Typical Distributors
14.3 Passive Immunizing Drugs against Rabies Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Passive Immunizing Drugs against Rabies Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Passive Immunizing Drugs against Rabies Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 3. Kedrion Biopharma Basic Information, Manufacturing Base and Competitors
Table 4. Kedrion Biopharma Major Business
Table 5. Kedrion Biopharma Passive Immunizing Drugs against Rabies Product and Services
Table 6. Kedrion Biopharma Passive Immunizing Drugs against Rabies Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 7. Kedrion Biopharma Recent Developments/Updates
Table 8. Grifols Basic Information, Manufacturing Base and Competitors
Table 9. Grifols Major Business
Table 10. Grifols Passive Immunizing Drugs against Rabies Product and Services
Table 11. Grifols Passive Immunizing Drugs against Rabies Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 12. Grifols Recent Developments/Updates
Table 13. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 14. Sanofi Pasteur Major Business
Table 15. Sanofi Pasteur Passive Immunizing Drugs against Rabies Product and Services
Table 16. Sanofi Pasteur Passive Immunizing Drugs against Rabies Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 17. Sanofi Pasteur Recent Developments/Updates
Table 18. Kamada Basic Information, Manufacturing Base and Competitors
Table 19. Kamada Major Business
Table 20. Kamada Passive Immunizing Drugs against Rabies Product and Services
Table 21. Kamada Passive Immunizing Drugs against Rabies Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 22. Kamada Recent Developments/Updates
Table 23. Zydus Lifesciences Basic Information, Manufacturing Base and Competitors
Table 24. Zydus Lifesciences Major Business
Table 25. Zydus Lifesciences Passive Immunizing Drugs against Rabies Product and Services
Table 26. Zydus Lifesciences Passive Immunizing Drugs against Rabies Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 27. Zydus Lifesciences Recent Developments/Updates
Table 28. Serum Institute of India Basic Information, Manufacturing Base and Competitors
Table 29. Serum Institute of India Major Business
Table 30. Serum Institute of India Passive Immunizing Drugs against Rabies Product and Services
Table 31. Serum Institute of India Passive Immunizing Drugs against Rabies Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 32. Serum Institute of India Recent Developments/Updates
Table 33. Sichuan Yuanda Shuyang Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 34. Sichuan Yuanda Shuyang Pharmaceutical Major Business
Table 35. Sichuan Yuanda Shuyang Pharmaceutical Passive Immunizing Drugs against Rabies Product and Services
Table 36. Sichuan Yuanda Shuyang Pharmaceutical Passive Immunizing Drugs against Rabies Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 37. Sichuan Yuanda Shuyang Pharmaceutical Recent Developments/Updates
Table 38. Sinopharm Group Basic Information, Manufacturing Base and Competitors
Table 39. Sinopharm Group Major Business
Table 40. Sinopharm Group Passive Immunizing Drugs against Rabies Product and Services
Table 41. Sinopharm Group Passive Immunizing Drugs against Rabies Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 42. Sinopharm Group Recent Developments/Updates
Table 43. Haffkine Bio-Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 44. Haffkine Bio-Pharmaceutical Major Business
Table 45. Haffkine Bio-Pharmaceutical Passive Immunizing Drugs against Rabies Product and Services
Table 46. Haffkine Bio-Pharmaceutical Passive Immunizing Drugs against Rabies Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 47. Haffkine Bio-Pharmaceutical Recent Developments/Updates
Table 48. Bharat Biotech Basic Information, Manufacturing Base and Competitors
Table 49. Bharat Biotech Major Business
Table 50. Bharat Biotech Passive Immunizing Drugs against Rabies Product and Services
Table 51. Bharat Biotech Passive Immunizing Drugs against Rabies Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 52. Bharat Biotech Recent Developments/Updates
Table 53. Sharon Bio-Medicine Basic Information, Manufacturing Base and Competitors
Table 54. Sharon Bio-Medicine Major Business
Table 55. Sharon Bio-Medicine Passive Immunizing Drugs against Rabies Product and Services
Table 56. Sharon Bio-Medicine Passive Immunizing Drugs against Rabies Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 57. Sharon Bio-Medicine Recent Developments/Updates
Table 58. Wuhan Institute of Biological Products Basic Information, Manufacturing Base and Competitors
Table 59. Wuhan Institute of Biological Products Major Business
Table 60. Wuhan Institute of Biological Products Passive Immunizing Drugs against Rabies Product and Services
Table 61. Wuhan Institute of Biological Products Passive Immunizing Drugs against Rabies Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 62. Wuhan Institute of Biological Products Recent Developments/Updates
Table 63. North China Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 64. North China Pharmaceutical Major Business
Table 65. North China Pharmaceutical Passive Immunizing Drugs against Rabies Product and Services
Table 66. North China Pharmaceutical Passive Immunizing Drugs against Rabies Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 67. North China Pharmaceutical Recent Developments/Updates
Table 68. Xingmeng Biopharmaceuticals (Suzhou) Basic Information, Manufacturing Base and Competitors
Table 69. Xingmeng Biopharmaceuticals (Suzhou) Major Business
Table 70. Xingmeng Biopharmaceuticals (Suzhou) Passive Immunizing Drugs against Rabies Product and Services
Table 71. Xingmeng Biopharmaceuticals (Suzhou) Passive Immunizing Drugs against Rabies Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 72. Xingmeng Biopharmaceuticals (Suzhou) Recent Developments/Updates
Table 73. Hualan Biological Engineering Basic Information, Manufacturing Base and Competitors
Table 74. Hualan Biological Engineering Major Business
Table 75. Hualan Biological Engineering Passive Immunizing Drugs against Rabies Product and Services
Table 76. Hualan Biological Engineering Passive Immunizing Drugs against Rabies Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 77. Hualan Biological Engineering Recent Developments/Updates
Table 78. Shanxi Kangbao Biological Product Basic Information, Manufacturing Base and Competitors
Table 79. Shanxi Kangbao Biological Product Major Business
Table 80. Shanxi Kangbao Biological Product Passive Immunizing Drugs against Rabies Product and Services
Table 81. Shanxi Kangbao Biological Product Passive Immunizing Drugs against Rabies Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 82. Shanxi Kangbao Biological Product Recent Developments/Updates
Table 83. Global Passive Immunizing Drugs against Rabies Sales Quantity by Manufacturer (2021-2026) & (K Dose)
Table 84. Global Passive Immunizing Drugs against Rabies Revenue by Manufacturer (2021-2026) & (USD Million)
Table 85. Global Passive Immunizing Drugs against Rabies Average Price by Manufacturer (2021-2026) & (US$/Dose)
Table 86. Market Position of Manufacturers in Passive Immunizing Drugs against Rabies, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 87. Head Office and Passive Immunizing Drugs against Rabies Production Site of Key Manufacturer
Table 88. Passive Immunizing Drugs against Rabies Market: Company Product Type Footprint
Table 89. Passive Immunizing Drugs against Rabies Market: Company Product Application Footprint
Table 90. Passive Immunizing Drugs against Rabies New Market Entrants and Barriers to Market Entry
Table 91. Passive Immunizing Drugs against Rabies Mergers, Acquisition, Agreements, and Collaborations
Table 92. Global Passive Immunizing Drugs against Rabies Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 93. Global Passive Immunizing Drugs against Rabies Sales Quantity by Region (2021-2026) & (K Dose)
Table 94. Global Passive Immunizing Drugs against Rabies Sales Quantity by Region (2027-2032) & (K Dose)
Table 95. Global Passive Immunizing Drugs against Rabies Consumption Value by Region (2021-2026) & (USD Million)
Table 96. Global Passive Immunizing Drugs against Rabies Consumption Value by Region (2027-2032) & (USD Million)
Table 97. Global Passive Immunizing Drugs against Rabies Average Price by Region (2021-2026) & (US$/Dose)
Table 98. Global Passive Immunizing Drugs against Rabies Average Price by Region (2027-2032) & (US$/Dose)
Table 99. Global Passive Immunizing Drugs against Rabies Sales Quantity by Type (2021-2026) & (K Dose)
Table 100. Global Passive Immunizing Drugs against Rabies Sales Quantity by Type (2027-2032) & (K Dose)
Table 101. Global Passive Immunizing Drugs against Rabies Consumption Value by Type (2021-2026) & (USD Million)
Table 102. Global Passive Immunizing Drugs against Rabies Consumption Value by Type (2027-2032) & (USD Million)
Table 103. Global Passive Immunizing Drugs against Rabies Average Price by Type (2021-2026) & (US$/Dose)
Table 104. Global Passive Immunizing Drugs against Rabies Average Price by Type (2027-2032) & (US$/Dose)
Table 105. Global Passive Immunizing Drugs against Rabies Sales Quantity by Application (2021-2026) & (K Dose)
Table 106. Global Passive Immunizing Drugs against Rabies Sales Quantity by Application (2027-2032) & (K Dose)
Table 107. Global Passive Immunizing Drugs against Rabies Consumption Value by Application (2021-2026) & (USD Million)
Table 108. Global Passive Immunizing Drugs against Rabies Consumption Value by Application (2027-2032) & (USD Million)
Table 109. Global Passive Immunizing Drugs against Rabies Average Price by Application (2021-2026) & (US$/Dose)
Table 110. Global Passive Immunizing Drugs against Rabies Average Price by Application (2027-2032) & (US$/Dose)
Table 111. North America Passive Immunizing Drugs against Rabies Sales Quantity by Type (2021-2026) & (K Dose)
Table 112. North America Passive Immunizing Drugs against Rabies Sales Quantity by Type (2027-2032) & (K Dose)
Table 113. North America Passive Immunizing Drugs against Rabies Sales Quantity by Application (2021-2026) & (K Dose)
Table 114. North America Passive Immunizing Drugs against Rabies Sales Quantity by Application (2027-2032) & (K Dose)
Table 115. North America Passive Immunizing Drugs against Rabies Sales Quantity by Country (2021-2026) & (K Dose)
Table 116. North America Passive Immunizing Drugs against Rabies Sales Quantity by Country (2027-2032) & (K Dose)
Table 117. North America Passive Immunizing Drugs against Rabies Consumption Value by Country (2021-2026) & (USD Million)
Table 118. North America Passive Immunizing Drugs against Rabies Consumption Value by Country (2027-2032) & (USD Million)
Table 119. Europe Passive Immunizing Drugs against Rabies Sales Quantity by Type (2021-2026) & (K Dose)
Table 120. Europe Passive Immunizing Drugs against Rabies Sales Quantity by Type (2027-2032) & (K Dose)
Table 121. Europe Passive Immunizing Drugs against Rabies Sales Quantity by Application (2021-2026) & (K Dose)
Table 122. Europe Passive Immunizing Drugs against Rabies Sales Quantity by Application (2027-2032) & (K Dose)
Table 123. Europe Passive Immunizing Drugs against Rabies Sales Quantity by Country (2021-2026) & (K Dose)
Table 124. Europe Passive Immunizing Drugs against Rabies Sales Quantity by Country (2027-2032) & (K Dose)
Table 125. Europe Passive Immunizing Drugs against Rabies Consumption Value by Country (2021-2026) & (USD Million)
Table 126. Europe Passive Immunizing Drugs against Rabies Consumption Value by Country (2027-2032) & (USD Million)
Table 127. Asia-Pacific Passive Immunizing Drugs against Rabies Sales Quantity by Type (2021-2026) & (K Dose)
Table 128. Asia-Pacific Passive Immunizing Drugs against Rabies Sales Quantity by Type (2027-2032) & (K Dose)
Table 129. Asia-Pacific Passive Immunizing Drugs against Rabies Sales Quantity by Application (2021-2026) & (K Dose)
Table 130. Asia-Pacific Passive Immunizing Drugs against Rabies Sales Quantity by Application (2027-2032) & (K Dose)
Table 131. Asia-Pacific Passive Immunizing Drugs against Rabies Sales Quantity by Region (2021-2026) & (K Dose)
Table 132. Asia-Pacific Passive Immunizing Drugs against Rabies Sales Quantity by Region (2027-2032) & (K Dose)
Table 133. Asia-Pacific Passive Immunizing Drugs against Rabies Consumption Value by Region (2021-2026) & (USD Million)
Table 134. Asia-Pacific Passive Immunizing Drugs against Rabies Consumption Value by Region (2027-2032) & (USD Million)
Table 135. South America Passive Immunizing Drugs against Rabies Sales Quantity by Type (2021-2026) & (K Dose)
Table 136. South America Passive Immunizing Drugs against Rabies Sales Quantity by Type (2027-2032) & (K Dose)
Table 137. South America Passive Immunizing Drugs against Rabies Sales Quantity by Application (2021-2026) & (K Dose)
Table 138. South America Passive Immunizing Drugs against Rabies Sales Quantity by Application (2027-2032) & (K Dose)
Table 139. South America Passive Immunizing Drugs against Rabies Sales Quantity by Country (2021-2026) & (K Dose)
Table 140. South America Passive Immunizing Drugs against Rabies Sales Quantity by Country (2027-2032) & (K Dose)
Table 141. South America Passive Immunizing Drugs against Rabies Consumption Value by Country (2021-2026) & (USD Million)
Table 142. South America Passive Immunizing Drugs against Rabies Consumption Value by Country (2027-2032) & (USD Million)
Table 143. Middle East & Africa Passive Immunizing Drugs against Rabies Sales Quantity by Type (2021-2026) & (K Dose)
Table 144. Middle East & Africa Passive Immunizing Drugs against Rabies Sales Quantity by Type (2027-2032) & (K Dose)
Table 145. Middle East & Africa Passive Immunizing Drugs against Rabies Sales Quantity by Application (2021-2026) & (K Dose)
Table 146. Middle East & Africa Passive Immunizing Drugs against Rabies Sales Quantity by Application (2027-2032) & (K Dose)
Table 147. Middle East & Africa Passive Immunizing Drugs against Rabies Sales Quantity by Country (2021-2026) & (K Dose)
Table 148. Middle East & Africa Passive Immunizing Drugs against Rabies Sales Quantity by Country (2027-2032) & (K Dose)
Table 149. Middle East & Africa Passive Immunizing Drugs against Rabies Consumption Value by Country (2021-2026) & (USD Million)
Table 150. Middle East & Africa Passive Immunizing Drugs against Rabies Consumption Value by Country (2027-2032) & (USD Million)
Table 151. Passive Immunizing Drugs against Rabies Raw Material
Table 152. Key Manufacturers of Passive Immunizing Drugs against Rabies Raw Materials
Table 153. Passive Immunizing Drugs against Rabies Typical Distributors
Table 154. Passive Immunizing Drugs against Rabies Typical Customers
Table 1. Global Passive Immunizing Drugs against Rabies Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Passive Immunizing Drugs against Rabies Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 3. Kedrion Biopharma Basic Information, Manufacturing Base and Competitors
Table 4. Kedrion Biopharma Major Business
Table 5. Kedrion Biopharma Passive Immunizing Drugs against Rabies Product and Services
Table 6. Kedrion Biopharma Passive Immunizing Drugs against Rabies Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 7. Kedrion Biopharma Recent Developments/Updates
Table 8. Grifols Basic Information, Manufacturing Base and Competitors
Table 9. Grifols Major Business
Table 10. Grifols Passive Immunizing Drugs against Rabies Product and Services
Table 11. Grifols Passive Immunizing Drugs against Rabies Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 12. Grifols Recent Developments/Updates
Table 13. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 14. Sanofi Pasteur Major Business
Table 15. Sanofi Pasteur Passive Immunizing Drugs against Rabies Product and Services
Table 16. Sanofi Pasteur Passive Immunizing Drugs against Rabies Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 17. Sanofi Pasteur Recent Developments/Updates
Table 18. Kamada Basic Information, Manufacturing Base and Competitors
Table 19. Kamada Major Business
Table 20. Kamada Passive Immunizing Drugs against Rabies Product and Services
Table 21. Kamada Passive Immunizing Drugs against Rabies Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 22. Kamada Recent Developments/Updates
Table 23. Zydus Lifesciences Basic Information, Manufacturing Base and Competitors
Table 24. Zydus Lifesciences Major Business
Table 25. Zydus Lifesciences Passive Immunizing Drugs against Rabies Product and Services
Table 26. Zydus Lifesciences Passive Immunizing Drugs against Rabies Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 27. Zydus Lifesciences Recent Developments/Updates
Table 28. Serum Institute of India Basic Information, Manufacturing Base and Competitors
Table 29. Serum Institute of India Major Business
Table 30. Serum Institute of India Passive Immunizing Drugs against Rabies Product and Services
Table 31. Serum Institute of India Passive Immunizing Drugs against Rabies Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 32. Serum Institute of India Recent Developments/Updates
Table 33. Sichuan Yuanda Shuyang Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 34. Sichuan Yuanda Shuyang Pharmaceutical Major Business
Table 35. Sichuan Yuanda Shuyang Pharmaceutical Passive Immunizing Drugs against Rabies Product and Services
Table 36. Sichuan Yuanda Shuyang Pharmaceutical Passive Immunizing Drugs against Rabies Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 37. Sichuan Yuanda Shuyang Pharmaceutical Recent Developments/Updates
Table 38. Sinopharm Group Basic Information, Manufacturing Base and Competitors
Table 39. Sinopharm Group Major Business
Table 40. Sinopharm Group Passive Immunizing Drugs against Rabies Product and Services
Table 41. Sinopharm Group Passive Immunizing Drugs against Rabies Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 42. Sinopharm Group Recent Developments/Updates
Table 43. Haffkine Bio-Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 44. Haffkine Bio-Pharmaceutical Major Business
Table 45. Haffkine Bio-Pharmaceutical Passive Immunizing Drugs against Rabies Product and Services
Table 46. Haffkine Bio-Pharmaceutical Passive Immunizing Drugs against Rabies Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 47. Haffkine Bio-Pharmaceutical Recent Developments/Updates
Table 48. Bharat Biotech Basic Information, Manufacturing Base and Competitors
Table 49. Bharat Biotech Major Business
Table 50. Bharat Biotech Passive Immunizing Drugs against Rabies Product and Services
Table 51. Bharat Biotech Passive Immunizing Drugs against Rabies Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 52. Bharat Biotech Recent Developments/Updates
Table 53. Sharon Bio-Medicine Basic Information, Manufacturing Base and Competitors
Table 54. Sharon Bio-Medicine Major Business
Table 55. Sharon Bio-Medicine Passive Immunizing Drugs against Rabies Product and Services
Table 56. Sharon Bio-Medicine Passive Immunizing Drugs against Rabies Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 57. Sharon Bio-Medicine Recent Developments/Updates
Table 58. Wuhan Institute of Biological Products Basic Information, Manufacturing Base and Competitors
Table 59. Wuhan Institute of Biological Products Major Business
Table 60. Wuhan Institute of Biological Products Passive Immunizing Drugs against Rabies Product and Services
Table 61. Wuhan Institute of Biological Products Passive Immunizing Drugs against Rabies Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 62. Wuhan Institute of Biological Products Recent Developments/Updates
Table 63. North China Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 64. North China Pharmaceutical Major Business
Table 65. North China Pharmaceutical Passive Immunizing Drugs against Rabies Product and Services
Table 66. North China Pharmaceutical Passive Immunizing Drugs against Rabies Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 67. North China Pharmaceutical Recent Developments/Updates
Table 68. Xingmeng Biopharmaceuticals (Suzhou) Basic Information, Manufacturing Base and Competitors
Table 69. Xingmeng Biopharmaceuticals (Suzhou) Major Business
Table 70. Xingmeng Biopharmaceuticals (Suzhou) Passive Immunizing Drugs against Rabies Product and Services
Table 71. Xingmeng Biopharmaceuticals (Suzhou) Passive Immunizing Drugs against Rabies Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 72. Xingmeng Biopharmaceuticals (Suzhou) Recent Developments/Updates
Table 73. Hualan Biological Engineering Basic Information, Manufacturing Base and Competitors
Table 74. Hualan Biological Engineering Major Business
Table 75. Hualan Biological Engineering Passive Immunizing Drugs against Rabies Product and Services
Table 76. Hualan Biological Engineering Passive Immunizing Drugs against Rabies Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 77. Hualan Biological Engineering Recent Developments/Updates
Table 78. Shanxi Kangbao Biological Product Basic Information, Manufacturing Base and Competitors
Table 79. Shanxi Kangbao Biological Product Major Business
Table 80. Shanxi Kangbao Biological Product Passive Immunizing Drugs against Rabies Product and Services
Table 81. Shanxi Kangbao Biological Product Passive Immunizing Drugs against Rabies Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 82. Shanxi Kangbao Biological Product Recent Developments/Updates
Table 83. Global Passive Immunizing Drugs against Rabies Sales Quantity by Manufacturer (2021-2026) & (K Dose)
Table 84. Global Passive Immunizing Drugs against Rabies Revenue by Manufacturer (2021-2026) & (USD Million)
Table 85. Global Passive Immunizing Drugs against Rabies Average Price by Manufacturer (2021-2026) & (US$/Dose)
Table 86. Market Position of Manufacturers in Passive Immunizing Drugs against Rabies, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 87. Head Office and Passive Immunizing Drugs against Rabies Production Site of Key Manufacturer
Table 88. Passive Immunizing Drugs against Rabies Market: Company Product Type Footprint
Table 89. Passive Immunizing Drugs against Rabies Market: Company Product Application Footprint
Table 90. Passive Immunizing Drugs against Rabies New Market Entrants and Barriers to Market Entry
Table 91. Passive Immunizing Drugs against Rabies Mergers, Acquisition, Agreements, and Collaborations
Table 92. Global Passive Immunizing Drugs against Rabies Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 93. Global Passive Immunizing Drugs against Rabies Sales Quantity by Region (2021-2026) & (K Dose)
Table 94. Global Passive Immunizing Drugs against Rabies Sales Quantity by Region (2027-2032) & (K Dose)
Table 95. Global Passive Immunizing Drugs against Rabies Consumption Value by Region (2021-2026) & (USD Million)
Table 96. Global Passive Immunizing Drugs against Rabies Consumption Value by Region (2027-2032) & (USD Million)
Table 97. Global Passive Immunizing Drugs against Rabies Average Price by Region (2021-2026) & (US$/Dose)
Table 98. Global Passive Immunizing Drugs against Rabies Average Price by Region (2027-2032) & (US$/Dose)
Table 99. Global Passive Immunizing Drugs against Rabies Sales Quantity by Type (2021-2026) & (K Dose)
Table 100. Global Passive Immunizing Drugs against Rabies Sales Quantity by Type (2027-2032) & (K Dose)
Table 101. Global Passive Immunizing Drugs against Rabies Consumption Value by Type (2021-2026) & (USD Million)
Table 102. Global Passive Immunizing Drugs against Rabies Consumption Value by Type (2027-2032) & (USD Million)
Table 103. Global Passive Immunizing Drugs against Rabies Average Price by Type (2021-2026) & (US$/Dose)
Table 104. Global Passive Immunizing Drugs against Rabies Average Price by Type (2027-2032) & (US$/Dose)
Table 105. Global Passive Immunizing Drugs against Rabies Sales Quantity by Application (2021-2026) & (K Dose)
Table 106. Global Passive Immunizing Drugs against Rabies Sales Quantity by Application (2027-2032) & (K Dose)
Table 107. Global Passive Immunizing Drugs against Rabies Consumption Value by Application (2021-2026) & (USD Million)
Table 108. Global Passive Immunizing Drugs against Rabies Consumption Value by Application (2027-2032) & (USD Million)
Table 109. Global Passive Immunizing Drugs against Rabies Average Price by Application (2021-2026) & (US$/Dose)
Table 110. Global Passive Immunizing Drugs against Rabies Average Price by Application (2027-2032) & (US$/Dose)
Table 111. North America Passive Immunizing Drugs against Rabies Sales Quantity by Type (2021-2026) & (K Dose)
Table 112. North America Passive Immunizing Drugs against Rabies Sales Quantity by Type (2027-2032) & (K Dose)
Table 113. North America Passive Immunizing Drugs against Rabies Sales Quantity by Application (2021-2026) & (K Dose)
Table 114. North America Passive Immunizing Drugs against Rabies Sales Quantity by Application (2027-2032) & (K Dose)
Table 115. North America Passive Immunizing Drugs against Rabies Sales Quantity by Country (2021-2026) & (K Dose)
Table 116. North America Passive Immunizing Drugs against Rabies Sales Quantity by Country (2027-2032) & (K Dose)
Table 117. North America Passive Immunizing Drugs against Rabies Consumption Value by Country (2021-2026) & (USD Million)
Table 118. North America Passive Immunizing Drugs against Rabies Consumption Value by Country (2027-2032) & (USD Million)
Table 119. Europe Passive Immunizing Drugs against Rabies Sales Quantity by Type (2021-2026) & (K Dose)
Table 120. Europe Passive Immunizing Drugs against Rabies Sales Quantity by Type (2027-2032) & (K Dose)
Table 121. Europe Passive Immunizing Drugs against Rabies Sales Quantity by Application (2021-2026) & (K Dose)
Table 122. Europe Passive Immunizing Drugs against Rabies Sales Quantity by Application (2027-2032) & (K Dose)
Table 123. Europe Passive Immunizing Drugs against Rabies Sales Quantity by Country (2021-2026) & (K Dose)
Table 124. Europe Passive Immunizing Drugs against Rabies Sales Quantity by Country (2027-2032) & (K Dose)
Table 125. Europe Passive Immunizing Drugs against Rabies Consumption Value by Country (2021-2026) & (USD Million)
Table 126. Europe Passive Immunizing Drugs against Rabies Consumption Value by Country (2027-2032) & (USD Million)
Table 127. Asia-Pacific Passive Immunizing Drugs against Rabies Sales Quantity by Type (2021-2026) & (K Dose)
Table 128. Asia-Pacific Passive Immunizing Drugs against Rabies Sales Quantity by Type (2027-2032) & (K Dose)
Table 129. Asia-Pacific Passive Immunizing Drugs against Rabies Sales Quantity by Application (2021-2026) & (K Dose)
Table 130. Asia-Pacific Passive Immunizing Drugs against Rabies Sales Quantity by Application (2027-2032) & (K Dose)
Table 131. Asia-Pacific Passive Immunizing Drugs against Rabies Sales Quantity by Region (2021-2026) & (K Dose)
Table 132. Asia-Pacific Passive Immunizing Drugs against Rabies Sales Quantity by Region (2027-2032) & (K Dose)
Table 133. Asia-Pacific Passive Immunizing Drugs against Rabies Consumption Value by Region (2021-2026) & (USD Million)
Table 134. Asia-Pacific Passive Immunizing Drugs against Rabies Consumption Value by Region (2027-2032) & (USD Million)
Table 135. South America Passive Immunizing Drugs against Rabies Sales Quantity by Type (2021-2026) & (K Dose)
Table 136. South America Passive Immunizing Drugs against Rabies Sales Quantity by Type (2027-2032) & (K Dose)
Table 137. South America Passive Immunizing Drugs against Rabies Sales Quantity by Application (2021-2026) & (K Dose)
Table 138. South America Passive Immunizing Drugs against Rabies Sales Quantity by Application (2027-2032) & (K Dose)
Table 139. South America Passive Immunizing Drugs against Rabies Sales Quantity by Country (2021-2026) & (K Dose)
Table 140. South America Passive Immunizing Drugs against Rabies Sales Quantity by Country (2027-2032) & (K Dose)
Table 141. South America Passive Immunizing Drugs against Rabies Consumption Value by Country (2021-2026) & (USD Million)
Table 142. South America Passive Immunizing Drugs against Rabies Consumption Value by Country (2027-2032) & (USD Million)
Table 143. Middle East & Africa Passive Immunizing Drugs against Rabies Sales Quantity by Type (2021-2026) & (K Dose)
Table 144. Middle East & Africa Passive Immunizing Drugs against Rabies Sales Quantity by Type (2027-2032) & (K Dose)
Table 145. Middle East & Africa Passive Immunizing Drugs against Rabies Sales Quantity by Application (2021-2026) & (K Dose)
Table 146. Middle East & Africa Passive Immunizing Drugs against Rabies Sales Quantity by Application (2027-2032) & (K Dose)
Table 147. Middle East & Africa Passive Immunizing Drugs against Rabies Sales Quantity by Country (2021-2026) & (K Dose)
Table 148. Middle East & Africa Passive Immunizing Drugs against Rabies Sales Quantity by Country (2027-2032) & (K Dose)
Table 149. Middle East & Africa Passive Immunizing Drugs against Rabies Consumption Value by Country (2021-2026) & (USD Million)
Table 150. Middle East & Africa Passive Immunizing Drugs against Rabies Consumption Value by Country (2027-2032) & (USD Million)
Table 151. Passive Immunizing Drugs against Rabies Raw Material
Table 152. Key Manufacturers of Passive Immunizing Drugs against Rabies Raw Materials
Table 153. Passive Immunizing Drugs against Rabies Typical Distributors
Table 154. Passive Immunizing Drugs against Rabies Typical Customers
LIST OF FIGURES
Figure 1. Passive Immunizing Drugs against Rabies Picture
Figure 2. Global Passive Immunizing Drugs against Rabies Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Passive Immunizing Drugs against Rabies Revenue Market Share by Type in 2025
Figure 4. Rabies Immunoglobulin Examples
Figure 5. Anti-rabies Serum Examples
Figure 6. Rabies Virus Monoclonal Antibody Examples
Figure 7. Global Passive Immunizing Drugs against Rabies Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 8. Global Passive Immunizing Drugs against Rabies Revenue Market Share by Application in 2025
Figure 9. Category II Exposure Examples
Figure 10. Category III Exposure Examples
Figure 11. Global Passive Immunizing Drugs against Rabies Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 12. Global Passive Immunizing Drugs against Rabies Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 13. Global Passive Immunizing Drugs against Rabies Sales Quantity (2021-2032) & (K Dose)
Figure 14. Global Passive Immunizing Drugs against Rabies Price (2021-2032) & (US$/Dose)
Figure 15. Global Passive Immunizing Drugs against Rabies Sales Quantity Market Share by Manufacturer in 2025
Figure 16. Global Passive Immunizing Drugs against Rabies Revenue Market Share by Manufacturer in 2025
Figure 17. Producer Shipments of Passive Immunizing Drugs against Rabies by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 18. Top 3 Passive Immunizing Drugs against Rabies Manufacturer (Revenue) Market Share in 2025
Figure 19. Top 6 Passive Immunizing Drugs against Rabies Manufacturer (Revenue) Market Share in 2025
Figure 20. Global Passive Immunizing Drugs against Rabies Sales Quantity Market Share by Region (2021-2032)
Figure 21. Global Passive Immunizing Drugs against Rabies Consumption Value Market Share by Region (2021-2032)
Figure 22. North America Passive Immunizing Drugs against Rabies Consumption Value (2021-2032) & (USD Million)
Figure 23. Europe Passive Immunizing Drugs against Rabies Consumption Value (2021-2032) & (USD Million)
Figure 24. Asia-Pacific Passive Immunizing Drugs against Rabies Consumption Value (2021-2032) & (USD Million)
Figure 25. South America Passive Immunizing Drugs against Rabies Consumption Value (2021-2032) & (USD Million)
Figure 26. Middle East & Africa Passive Immunizing Drugs against Rabies Consumption Value (2021-2032) & (USD Million)
Figure 27. Global Passive Immunizing Drugs against Rabies Sales Quantity Market Share by Type (2021-2032)
Figure 28. Global Passive Immunizing Drugs against Rabies Consumption Value Market Share by Type (2021-2032)
Figure 29. Global Passive Immunizing Drugs against Rabies Average Price by Type (2021-2032) & (US$/Dose)
Figure 30. Global Passive Immunizing Drugs against Rabies Sales Quantity Market Share by Application (2021-2032)
Figure 31. Global Passive Immunizing Drugs against Rabies Revenue Market Share by Application (2021-2032)
Figure 32. Global Passive Immunizing Drugs against Rabies Average Price by Application (2021-2032) & (US$/Dose)
Figure 33. North America Passive Immunizing Drugs against Rabies Sales Quantity Market Share by Type (2021-2032)
Figure 34. North America Passive Immunizing Drugs against Rabies Sales Quantity Market Share by Application (2021-2032)
Figure 35. North America Passive Immunizing Drugs against Rabies Sales Quantity Market Share by Country (2021-2032)
Figure 36. North America Passive Immunizing Drugs against Rabies Consumption Value Market Share by Country (2021-2032)
Figure 37. United States Passive Immunizing Drugs against Rabies Consumption Value (2021-2032) & (USD Million)
Figure 38. Canada Passive Immunizing Drugs against Rabies Consumption Value (2021-2032) & (USD Million)
Figure 39. Mexico Passive Immunizing Drugs against Rabies Consumption Value (2021-2032) & (USD Million)
Figure 40. Europe Passive Immunizing Drugs against Rabies Sales Quantity Market Share by Type (2021-2032)
Figure 41. Europe Passive Immunizing Drugs against Rabies Sales Quantity Market Share by Application (2021-2032)
Figure 42. Europe Passive Immunizing Drugs against Rabies Sales Quantity Market Share by Country (2021-2032)
Figure 43. Europe Passive Immunizing Drugs against Rabies Consumption Value Market Share by Country (2021-2032)
Figure 44. Germany Passive Immunizing Drugs against Rabies Consumption Value (2021-2032) & (USD Million)
Figure 45. France Passive Immunizing Drugs against Rabies Consumption Value (2021-2032) & (USD Million)
Figure 46. United Kingdom Passive Immunizing Drugs against Rabies Consumption Value (2021-2032) & (USD Million)
Figure 47. Russia Passive Immunizing Drugs against Rabies Consumption Value (2021-2032) & (USD Million)
Figure 48. Italy Passive Immunizing Drugs against Rabies Consumption Value (2021-2032) & (USD Million)
Figure 49. Asia-Pacific Passive Immunizing Drugs against Rabies Sales Quantity Market Share by Type (2021-2032)
Figure 50. Asia-Pacific Passive Immunizing Drugs against Rabies Sales Quantity Market Share by Application (2021-2032)
Figure 51. Asia-Pacific Passive Immunizing Drugs against Rabies Sales Quantity Market Share by Region (2021-2032)
Figure 52. Asia-Pacific Passive Immunizing Drugs against Rabies Consumption Value Market Share by Region (2021-2032)
Figure 53. China Passive Immunizing Drugs against Rabies Consumption Value (2021-2032) & (USD Million)
Figure 54. Japan Passive Immunizing Drugs against Rabies Consumption Value (2021-2032) & (USD Million)
Figure 55. South Korea Passive Immunizing Drugs against Rabies Consumption Value (2021-2032) & (USD Million)
Figure 56. India Passive Immunizing Drugs against Rabies Consumption Value (2021-2032) & (USD Million)
Figure 57. Southeast Asia Passive Immunizing Drugs against Rabies Consumption Value (2021-2032) & (USD Million)
Figure 58. Australia Passive Immunizing Drugs against Rabies Consumption Value (2021-2032) & (USD Million)
Figure 59. South America Passive Immunizing Drugs against Rabies Sales Quantity Market Share by Type (2021-2032)
Figure 60. South America Passive Immunizing Drugs against Rabies Sales Quantity Market Share by Application (2021-2032)
Figure 61. South America Passive Immunizing Drugs against Rabies Sales Quantity Market Share by Country (2021-2032)
Figure 62. South America Passive Immunizing Drugs against Rabies Consumption Value Market Share by Country (2021-2032)
Figure 63. Brazil Passive Immunizing Drugs against Rabies Consumption Value (2021-2032) & (USD Million)
Figure 64. Argentina Passive Immunizing Drugs against Rabies Consumption Value (2021-2032) & (USD Million)
Figure 65. Middle East & Africa Passive Immunizing Drugs against Rabies Sales Quantity Market Share by Type (2021-2032)
Figure 66. Middle East & Africa Passive Immunizing Drugs against Rabies Sales Quantity Market Share by Application (2021-2032)
Figure 67. Middle East & Africa Passive Immunizing Drugs against Rabies Sales Quantity Market Share by Country (2021-2032)
Figure 68. Middle East & Africa Passive Immunizing Drugs against Rabies Consumption Value Market Share by Country (2021-2032)
Figure 69. Turkey Passive Immunizing Drugs against Rabies Consumption Value (2021-2032) & (USD Million)
Figure 70. Egypt Passive Immunizing Drugs against Rabies Consumption Value (2021-2032) & (USD Million)
Figure 71. Saudi Arabia Passive Immunizing Drugs against Rabies Consumption Value (2021-2032) & (USD Million)
Figure 72. South Africa Passive Immunizing Drugs against Rabies Consumption Value (2021-2032) & (USD Million)
Figure 73. Passive Immunizing Drugs against Rabies Market Drivers
Figure 74. Passive Immunizing Drugs against Rabies Market Restraints
Figure 75. Passive Immunizing Drugs against Rabies Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Passive Immunizing Drugs against Rabies in 2025
Figure 78. Manufacturing Process Analysis of Passive Immunizing Drugs against Rabies
Figure 79. Passive Immunizing Drugs against Rabies Industrial Chain
Figure 80. Sales Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
Figure 1. Passive Immunizing Drugs against Rabies Picture
Figure 2. Global Passive Immunizing Drugs against Rabies Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Passive Immunizing Drugs against Rabies Revenue Market Share by Type in 2025
Figure 4. Rabies Immunoglobulin Examples
Figure 5. Anti-rabies Serum Examples
Figure 6. Rabies Virus Monoclonal Antibody Examples
Figure 7. Global Passive Immunizing Drugs against Rabies Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 8. Global Passive Immunizing Drugs against Rabies Revenue Market Share by Application in 2025
Figure 9. Category II Exposure Examples
Figure 10. Category III Exposure Examples
Figure 11. Global Passive Immunizing Drugs against Rabies Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 12. Global Passive Immunizing Drugs against Rabies Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 13. Global Passive Immunizing Drugs against Rabies Sales Quantity (2021-2032) & (K Dose)
Figure 14. Global Passive Immunizing Drugs against Rabies Price (2021-2032) & (US$/Dose)
Figure 15. Global Passive Immunizing Drugs against Rabies Sales Quantity Market Share by Manufacturer in 2025
Figure 16. Global Passive Immunizing Drugs against Rabies Revenue Market Share by Manufacturer in 2025
Figure 17. Producer Shipments of Passive Immunizing Drugs against Rabies by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 18. Top 3 Passive Immunizing Drugs against Rabies Manufacturer (Revenue) Market Share in 2025
Figure 19. Top 6 Passive Immunizing Drugs against Rabies Manufacturer (Revenue) Market Share in 2025
Figure 20. Global Passive Immunizing Drugs against Rabies Sales Quantity Market Share by Region (2021-2032)
Figure 21. Global Passive Immunizing Drugs against Rabies Consumption Value Market Share by Region (2021-2032)
Figure 22. North America Passive Immunizing Drugs against Rabies Consumption Value (2021-2032) & (USD Million)
Figure 23. Europe Passive Immunizing Drugs against Rabies Consumption Value (2021-2032) & (USD Million)
Figure 24. Asia-Pacific Passive Immunizing Drugs against Rabies Consumption Value (2021-2032) & (USD Million)
Figure 25. South America Passive Immunizing Drugs against Rabies Consumption Value (2021-2032) & (USD Million)
Figure 26. Middle East & Africa Passive Immunizing Drugs against Rabies Consumption Value (2021-2032) & (USD Million)
Figure 27. Global Passive Immunizing Drugs against Rabies Sales Quantity Market Share by Type (2021-2032)
Figure 28. Global Passive Immunizing Drugs against Rabies Consumption Value Market Share by Type (2021-2032)
Figure 29. Global Passive Immunizing Drugs against Rabies Average Price by Type (2021-2032) & (US$/Dose)
Figure 30. Global Passive Immunizing Drugs against Rabies Sales Quantity Market Share by Application (2021-2032)
Figure 31. Global Passive Immunizing Drugs against Rabies Revenue Market Share by Application (2021-2032)
Figure 32. Global Passive Immunizing Drugs against Rabies Average Price by Application (2021-2032) & (US$/Dose)
Figure 33. North America Passive Immunizing Drugs against Rabies Sales Quantity Market Share by Type (2021-2032)
Figure 34. North America Passive Immunizing Drugs against Rabies Sales Quantity Market Share by Application (2021-2032)
Figure 35. North America Passive Immunizing Drugs against Rabies Sales Quantity Market Share by Country (2021-2032)
Figure 36. North America Passive Immunizing Drugs against Rabies Consumption Value Market Share by Country (2021-2032)
Figure 37. United States Passive Immunizing Drugs against Rabies Consumption Value (2021-2032) & (USD Million)
Figure 38. Canada Passive Immunizing Drugs against Rabies Consumption Value (2021-2032) & (USD Million)
Figure 39. Mexico Passive Immunizing Drugs against Rabies Consumption Value (2021-2032) & (USD Million)
Figure 40. Europe Passive Immunizing Drugs against Rabies Sales Quantity Market Share by Type (2021-2032)
Figure 41. Europe Passive Immunizing Drugs against Rabies Sales Quantity Market Share by Application (2021-2032)
Figure 42. Europe Passive Immunizing Drugs against Rabies Sales Quantity Market Share by Country (2021-2032)
Figure 43. Europe Passive Immunizing Drugs against Rabies Consumption Value Market Share by Country (2021-2032)
Figure 44. Germany Passive Immunizing Drugs against Rabies Consumption Value (2021-2032) & (USD Million)
Figure 45. France Passive Immunizing Drugs against Rabies Consumption Value (2021-2032) & (USD Million)
Figure 46. United Kingdom Passive Immunizing Drugs against Rabies Consumption Value (2021-2032) & (USD Million)
Figure 47. Russia Passive Immunizing Drugs against Rabies Consumption Value (2021-2032) & (USD Million)
Figure 48. Italy Passive Immunizing Drugs against Rabies Consumption Value (2021-2032) & (USD Million)
Figure 49. Asia-Pacific Passive Immunizing Drugs against Rabies Sales Quantity Market Share by Type (2021-2032)
Figure 50. Asia-Pacific Passive Immunizing Drugs against Rabies Sales Quantity Market Share by Application (2021-2032)
Figure 51. Asia-Pacific Passive Immunizing Drugs against Rabies Sales Quantity Market Share by Region (2021-2032)
Figure 52. Asia-Pacific Passive Immunizing Drugs against Rabies Consumption Value Market Share by Region (2021-2032)
Figure 53. China Passive Immunizing Drugs against Rabies Consumption Value (2021-2032) & (USD Million)
Figure 54. Japan Passive Immunizing Drugs against Rabies Consumption Value (2021-2032) & (USD Million)
Figure 55. South Korea Passive Immunizing Drugs against Rabies Consumption Value (2021-2032) & (USD Million)
Figure 56. India Passive Immunizing Drugs against Rabies Consumption Value (2021-2032) & (USD Million)
Figure 57. Southeast Asia Passive Immunizing Drugs against Rabies Consumption Value (2021-2032) & (USD Million)
Figure 58. Australia Passive Immunizing Drugs against Rabies Consumption Value (2021-2032) & (USD Million)
Figure 59. South America Passive Immunizing Drugs against Rabies Sales Quantity Market Share by Type (2021-2032)
Figure 60. South America Passive Immunizing Drugs against Rabies Sales Quantity Market Share by Application (2021-2032)
Figure 61. South America Passive Immunizing Drugs against Rabies Sales Quantity Market Share by Country (2021-2032)
Figure 62. South America Passive Immunizing Drugs against Rabies Consumption Value Market Share by Country (2021-2032)
Figure 63. Brazil Passive Immunizing Drugs against Rabies Consumption Value (2021-2032) & (USD Million)
Figure 64. Argentina Passive Immunizing Drugs against Rabies Consumption Value (2021-2032) & (USD Million)
Figure 65. Middle East & Africa Passive Immunizing Drugs against Rabies Sales Quantity Market Share by Type (2021-2032)
Figure 66. Middle East & Africa Passive Immunizing Drugs against Rabies Sales Quantity Market Share by Application (2021-2032)
Figure 67. Middle East & Africa Passive Immunizing Drugs against Rabies Sales Quantity Market Share by Country (2021-2032)
Figure 68. Middle East & Africa Passive Immunizing Drugs against Rabies Consumption Value Market Share by Country (2021-2032)
Figure 69. Turkey Passive Immunizing Drugs against Rabies Consumption Value (2021-2032) & (USD Million)
Figure 70. Egypt Passive Immunizing Drugs against Rabies Consumption Value (2021-2032) & (USD Million)
Figure 71. Saudi Arabia Passive Immunizing Drugs against Rabies Consumption Value (2021-2032) & (USD Million)
Figure 72. South Africa Passive Immunizing Drugs against Rabies Consumption Value (2021-2032) & (USD Million)
Figure 73. Passive Immunizing Drugs against Rabies Market Drivers
Figure 74. Passive Immunizing Drugs against Rabies Market Restraints
Figure 75. Passive Immunizing Drugs against Rabies Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Passive Immunizing Drugs against Rabies in 2025
Figure 78. Manufacturing Process Analysis of Passive Immunizing Drugs against Rabies
Figure 79. Passive Immunizing Drugs against Rabies Industrial Chain
Figure 80. Sales Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
